New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
16:42 EDTRGDORegado Biosciences reports Q2 EPS (63c), consensus (51c)
Cash and cash equivalents at June 30, totaled $72.7M compared to $30.7M at December 31, 2013.
News For RGDO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 10, 2014
07:31 EDTRGDORegado Biosciences appoints Michael Metzger CEO
Regado Biosciences announced the appointment of Michael Metzger, President of Regado, to the additional post of CEO and as a member of the board effective immediately. Metzger previously served as president and chief operating officer of Regado. He replaces David Mazzo, who has resigned from the company.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use